The Diabetes Control and Complications Trial demonstrated the efficacy of intensive therapy involving multiple daily injections or continuous subcutaneous insulin infusion using short-acting (regular) and intermediate-acting (NPH) human insulins [11,12,13]. Here, INS is linked to diabetes mellitus.